Sam, thanks for the post. We need patience here. I own a stock called ICN Pharmaceuticals (ICN). I bought it at $21. For one year, the stock did absolutely nothing for me. It is frustrating at times. The earnings are good and they are rapidly locking up Eastern European pharmaceutical market. One analyst pegged 1998 EPS at $3.00, but stock was selling at $21. Then, three, four weeks ago, Hoffman LaRouche made an equity investment in ICN. Kabooooommm, the stock took off. Shot up from $21 to $34 in no time. It is finally discovered by Wall Street. ICN is still cheap. I am going to double down.
I am sure Endosonics' earnings beating performance is not forgotten. Fund managers are always searching for earnings-beating stocks. They will come around to ESON. When that happens, the stock is gone very quickly. We must be in the train sitting, otherwise we will never get on the train.
Peter, have you bought in or still watching ? You have to get on the train now (get a small position) or it may leave the station at 1,000 mph. Don't worry about competitor's product. Competition is always there.
Jimmy |
